AC Immune SA
NASDAQ:ACIU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Ping An Insurance Group Co of China Ltd
HKEX:2318
|
CN |
|
K
|
Kambi Group PLC
STO:KAMBI
|
MT |
|
Suzhou Dongshan Precision Manufacturing Co Ltd
SZSE:002384
|
CN |
|
B
|
Buriram Sugar Group Power Plant Infrastructure Fund
SET:BRRGIF
|
TH |
|
Jiangsu DongHua Testing Technology Co Ltd
SZSE:300354
|
CN |
|
S
|
Sanichi Technology Bhd
KLSE:SANICHI
|
MY |
|
Suzhou Gold Mantis Construction Decoration Co Ltd
SZSE:002081
|
CN |
During the last 3 months AC Immune SA insiders bought 31.4k USD , and sold 31.4k USD worth of shares. The stock price has dropped by 12% over this period (open performance analysis).
The last transaction was made on
Apr 15, 2026
by
Pfeifer Andrea
, who
sold
31.4k USD
worth of 
ACIU shares.
During the last 3 months AC Immune SA insiders bought 31.4k USD , and sold 31.4k USD worth of shares. The stock price has dropped by 12% over this period (open performance analysis).
The last transaction was made on
Apr 15, 2026
by
Pfeifer Andrea
, who
sold
31.4k USD
worth of ACIU shares.
AC Immune SA
Glance View
AC Immune SA engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. The company is headquartered in Lausanne, Vaud and currently employs 143 full-time employees. The company went IPO on 2016-09-23. The firm focuses on precision medicine for neurodegenerative diseases. The company designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The firm's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. The company has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
